Mighty Therapeutics Holdings Inc.

Mighty Therapeutics

This company develops mitochondrial-targeted therapies for patients with rare genetic conditions like Barth syndrome and common age-related diseases.

Pretzel Therapeutics

This biotechnology company develops small-molecule therapies for patients with mitochondrial dysfunction, including rare genetic conditions and common neurodegenerative diseases.

Abliva

This biopharmaceutical company develops novel medicines for patients suffering from rare and severe primary mitochondrial diseases.

Mitokinin

This biotechnology company develops small molecule drugs to treat Parkinson's disease and other neurodegenerative conditions for patients and healthcare providers.

Mair Therapeutics

This biotechnology company develops small-molecule therapies targeting lysosomal ion channels to treat neurodegenerative disorders such as Parkinson's disease for patients and healthcare institutions.

Muna Therapeutics

This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.

Stealth Bio

This biotechnology firm develops mitochondrial therapies, including an injectable medicine for patients with the rare genetic condition Barth syndrome.

MitoImmune Therapeutics

This biotechnology firm develops mitochondrial-targeted therapies for patients with inflammatory and rare diseases, including cancer treatment side effects like oral mucositis.